Prognostic factors related to overall survival in adolescent and young adults with medulloblastoma: A systematic review.
Han YanVeda ZabihUte BartelsSunit DasPaul C NathanSumit GuptaPublished in: Neuro-oncology advances (2022)
Prognostication and treatment of AYA medulloblastoma is limited by a dearth of primary evidence and lack of specificity for patients aged 15-39. Dedicated prospective trials to delineate the benefit of various chemotherapy and radiation regimens are required in this population to identify prognosticators and ideal treatment regimens.